Table 1 Clinical data, demographics, stage, chemotherapy, and key mutational status in GSE39582 [45] and GSE17536 [48] datasets
From: Refining colorectal cancer classification and clinical stratification through a single-cell atlas
Characteristic | GSE39582 (N = 502) | GSE17536 (N = 138) |
|---|---|---|
Age at diagnosis | ||
 Median (IQR) | 69 (59–76.9) | 67 (57–75) |
Gender | ||
 Male | 276 (45%) | 71 (51%) |
 Female | 226 (55%) | 67 (49%) |
Tumor stage | ||
 1 | 33 (6.6%) | 24 (17%) |
 2 | 264 (52.6%) | 57 (41%) |
 3 | 205 (40.8%) | 57 (41%) |
KRAS | ||
 M | 184 (38%) | – |
 WT | 297 (62%) | – |
 NA | 21 | – |
BRAF | ||
 M | 45 (10%) | – |
 WT | 403 (90%) | – |
 NA | 54 | – |
TP53 | ||
 M | 169 (53%) | – |
 WT | 147 (47%) | – |
 NA | 186 | – |
Chemotherapy | ||
 Y | 203 (41%) |  |
 N | 297 (59%) |  |
 NA | 2 |  |
Grade | ||
 WD | – | 15 (11%) |
 MD | – | 106 (77%) |
 PD | – | 17 (12%) |